Publications by authors named "T Grossman"

Newly approved subunit and mRNA vaccines for respiratory syncytial virus (RSV) demonstrate effectiveness in preventing severe disease, with protection exceeding 80% primarily through the generation of antibodies. An alternative vaccine platform called self-amplifying RNA (saRNA) holds promise in eliciting humoral and cellular immune responses. We evaluate the immunogenicity of a lipid nanoparticle (LNP)-formulated saRNA vaccine called SMARRT.

View Article and Find Full Text PDF

Pompe disease (PD) is a progressive myopathy caused by the aberrant accumulation of glycogen in skeletal and cardiac muscle resulting from the deficiency of the enzyme acid alpha-glucosidase (GAA). Administration of recombinant human GAA as enzyme replacement therapy (ERT) works well in alleviating the cardiac manifestations of PD but loses sustained benefit in ameliorating the skeletal muscle pathology. The limited efficacy of ERT in skeletal muscle is partially attributable to its inability to curb the accumulation of new glycogen produced by the muscle enzyme glycogen synthase 1 (GYS1).

View Article and Find Full Text PDF

Multisystem inflammatory syndrome in children (MIS-C), a new condition related to coronavirus disease 2019 (COVID-19) in the pediatric population, was recognized by physicians in the United Kingdom in April 2020. Given those up to the age of 21 years can be affected, pregnant adolescents and young adults are susceptible. However, there is scant information on how MIS-C may affect pregnancy and whether the presentation differs in the pregnant population.

View Article and Find Full Text PDF

We report a study investigating the viability of using interactive visualizations to aid architectural design with building codes. While visualizations have been used to support general architectural design exploration, existing computational solutions treat building codes as separate from, rather than part of, the design process, creating challenges for architects. Through a series of participatory design studies with professional architects, we found that interactive visualizations have promising potential to aid design exploration and sensemaking in early stages of architectural design by providing feedback about potential allowances and consequences of design decisions.

View Article and Find Full Text PDF
Article Synopsis
  • Artemisinin-based combination therapies (ACTs) are the first-line treatment for uncomplicated Plasmodium falciparum malaria, but mutations in specific genes can affect treatment efficacy.
  • A study of Israeli travelers returning with malaria showed that while there were no mutations in the Pfkelch13 gene associated with treatment failure, the P76S mutation in the Pfcoronin gene was more common in patients who did not respond to artemether-lumefantrine (AL).
  • The treatment failure rates for malaria in this cohort increased over the years, highlighting the growing concern about drug resistance in malaria infections sourced from sub-Saharan Africa.
View Article and Find Full Text PDF